ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS
申请人:Jackson Paul F.
公开号:US20110105492A1
公开(公告)日:2011-05-05
This invention relates to a novel arylindenopyrimidine, A, and its therapeutic and prophylactic uses. Disorders treated and/or prevented include Parkinson's Disease
wherein X, R
2
, R
3
, and R
4
are as defined in the specification.
这项发明涉及一种新的芳基吲哚吡啶,A,及其治疗和预防用途。治疗和/或预防的疾病包括帕金森病,其中X,R2,R3和R4如规范中定义。